BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kim EY, Yazdizadeh Shotorbani P, Dryer SE. Trpc6 inactivation confers protection in a model of severe nephrosis in rats. J Mol Med (Berl) 2018;96:631-44. [PMID: 29785489 DOI: 10.1007/s00109-018-1648-3] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 6.8] [Reference Citation Analysis]
Number Citing Articles
1 Hall G, Wang L, Spurney RF. TRPC Channels in Proteinuric Kidney Diseases. Cells 2019;9:E44. [PMID: 31877991 DOI: 10.3390/cells9010044] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
2 Lindemann O, Rossaint J, Najder K, Schimmelpfennig S, Hofschröer V, Wälte M, Fels B, Oberleithner H, Zarbock A, Schwab A. Intravascular adhesion and recruitment of neutrophils in response to CXCL1 depends on their TRPC6 channels. J Mol Med (Berl) 2020;98:349-60. [PMID: 31950205 DOI: 10.1007/s00109-020-01872-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
3 Hassanzadeh Khayyat N, Kim EY, Dryer SE. TRPC6 inactivation does not protect against diabetic kidney disease in streptozotocin (STZ)-treated Sprague-Dawley rats. FASEB Bioadv 2019;1:773-82. [PMID: 32123821 DOI: 10.1096/fba.2019-00077] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
4 Fiedler S, Storch U, Erdogmus S, Gudermann T, Mederos Y Schnitzler M, Dietrich A. Small Fluorescein Arsenical Hairpin-Based Förster Resonance Energy Transfer Analysis Reveals Changes in Amino- to Carboxyl-Terminal Interactions upon OAG Activation of Classical Transient Receptor Potential 6. Mol Pharmacol 2019;96:90-8. [PMID: 31171574 DOI: 10.1124/mol.119.115949] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
5 Kim EY, Dryer SE. Effects of TRPC6 Inactivation on Glomerulosclerosis and Renal Fibrosis in Aging Rats. Cells 2021;10:856. [PMID: 33918778 DOI: 10.3390/cells10040856] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Ramirez GA, Coletto LA, Sciorati C, Bozzolo EP, Manunta P, Rovere-Querini P, Manfredi AA. Ion Channels and Transporters in Inflammation: Special Focus on TRP Channels and TRPC6. Cells 2018;7:E70. [PMID: 29973568 DOI: 10.3390/cells7070070] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 5.8] [Reference Citation Analysis]
7 Staruschenko A, Spires D, Palygin O. Role of TRPC6 in Progression of Diabetic Kidney Disease. Curr Hypertens Rep 2019;21:48. [PMID: 31115705 DOI: 10.1007/s11906-019-0960-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
8 Lu XY, Liu BC, Cao YZ, Song C, Su H, Chen G, Klein JD, Zhang HX, Wang LH, Ma HP. High glucose reduces expression of podocin in cultured human podocytes by stimulating TRPC6. Am J Physiol Renal Physiol 2019;317:F1605-11. [PMID: 31566428 DOI: 10.1152/ajprenal.00215.2019] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
9 Kim EY, Hassanzadeh Khayyat N, Dryer SE. Mechanisms underlying modulation of podocyte TRPC6 channels by suPAR: Role of NADPH oxidases and Src family tyrosine kinases. Biochim Biophys Acta Mol Basis Dis 2018;1864:3527-36. [PMID: 30293571 DOI: 10.1016/j.bbadis.2018.08.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
10 Yadav S, Gupta K, Deshmukh K, Bhardwaj L, Dahiya A, Krishan P, Singh G. Calcium sensing receptor as a novel target for treatment of sepsis induced cardio-renal syndrome: Need for exploring mechanisms. Drug Dev Res 2021;82:305-8. [PMID: 33527497 DOI: 10.1002/ddr.21797] [Reference Citation Analysis]
11 Dryer SE, Kim EY. Permeation and Rectification in Canonical Transient Receptor Potential-6 (TRPC6) Channels. Front Physiol 2018;9:1055. [PMID: 30123138 DOI: 10.3389/fphys.2018.01055] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
12 Staruschenko A. TRPC6 in diabetic kidney disease: good guy or bad guy? Kidney Int 2019;95:256-8. [PMID: 30665563 DOI: 10.1016/j.kint.2018.10.027] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
13 Chenouard V, Remy S, Tesson L, Ménoret S, Ouisse LH, Cherifi Y, Anegon I. Advances in Genome Editing and Application to the Generation of Genetically Modified Rat Models. Front Genet 2021;12:615491. [PMID: 33959146 DOI: 10.3389/fgene.2021.615491] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
14 Spires D, Ilatovskaya DV, Levchenko V, North PE, Geurts AM, Palygin O, Staruschenko A. Protective role of Trpc6 knockout in the progression of diabetic kidney disease. Am J Physiol Renal Physiol 2018;315:F1091-7. [PMID: 29923767 DOI: 10.1152/ajprenal.00155.2018] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 7.3] [Reference Citation Analysis]
15 Kim EY, Dryer SE. TRPC6 Inactivation Reduces Albuminuria Induced by Protein Overload in Sprague Dawley Rats. Cells 2022;11:1985. [DOI: 10.3390/cells11131985] [Reference Citation Analysis]
16 't Hart D, Li J, van der Vlag J, Nijenhuis T. Repurposing Riociguat to Target a Novel Paracrine Nitric Oxide-TRPC6 Pathway to Prevent Podocyte Injury. Int J Mol Sci 2021;22:12485. [PMID: 34830371 DOI: 10.3390/ijms222212485] [Reference Citation Analysis]
17 Kim EY, Shotorbani PY, Dryer SE. TRPC6 inactivation does not affect loss of renal function in nephrotoxic serum glomerulonephritis in rats, but reduces severity of glomerular lesions. Biochem Biophys Rep 2019;17:139-50. [PMID: 30662960 DOI: 10.1016/j.bbrep.2018.12.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
18 Golosova D, Palygin O, Bohovyk R, Klemens CA, Levchenko V, Spires DR, Isaeva E, El-Meanawy A, Staruschenko A. Role of opioid signaling in kidney damage during the development of salt-induced hypertension. Life Sci Alliance 2020;3:e202000853. [PMID: 33046522 DOI: 10.26508/lsa.202000853] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Pablo JL, Greka A. Charting a TRP to Novel Therapeutic Destinations for Kidney Diseases. Trends Pharmacol Sci 2019;40:911-8. [PMID: 31704171 DOI: 10.1016/j.tips.2019.10.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
20 Spires D, Manis AD, Staruschenko A. Ion channels and transporters in diabetic kidney disease. Curr Top Membr 2019;83:353-96. [PMID: 31196609 DOI: 10.1016/bs.ctm.2019.01.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
21 Zhang Y, Yin N, Sun A, Wu Q, Hu W, Hou X, Zeng X, Zhu M, Liao Y. Transient Receptor Potential Channel 6 Knockout Ameliorates Kidney Fibrosis by Inhibition of Epithelial-Mesenchymal Transition. Front Cell Dev Biol 2020;8:602703. [PMID: 33520986 DOI: 10.3389/fcell.2020.602703] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Dou Y, Shang Y, Shen Y, Qu J, Liu C, Cao J. Baicalin alleviates adriamycin-induced focal segmental glomerulosclerosis and proteinuria by inhibiting the Notch1-Snail axis mediated podocyte EMT. Life Sciences 2020;257:118010. [DOI: 10.1016/j.lfs.2020.118010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 Khayyat NH, Tomilin VN, Zaika O, Pochynyuk O. Polymodal roles of TRPC3 channel in the kidney. Channels (Austin) 2020;14:257-67. [PMID: 32787494 DOI: 10.1080/19336950.2020.1804153] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Dryer SE, Roshanravan H, Kim EY. TRPC channels: Regulation, dysregulation and contributions to chronic kidney disease. Biochim Biophys Acta Mol Basis Dis 2019;1865:1041-66. [PMID: 30953689 DOI: 10.1016/j.bbadis.2019.04.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 6.3] [Reference Citation Analysis]
25 Zhou Y, Kim C, Pablo JLB, Zhang F, Jung JY, Xiao L, Bazua-Valenti S, Emani M, Hopkins CR, Weins A, Greka A. TRPC5 Channel Inhibition Protects Podocytes in Puromycin-Aminonucleoside Induced Nephrosis Models. Front Med (Lausanne) 2021;8:721865. [PMID: 34621762 DOI: 10.3389/fmed.2021.721865] [Reference Citation Analysis]
26 Wang L, Chang JH, Buckley AF, Spurney RF. Knockout of TRPC6 promotes insulin resistance and exacerbates glomerular injury in Akita mice. Kidney Int 2019;95:321-32. [PMID: 30665571 DOI: 10.1016/j.kint.2018.09.026] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 9.5] [Reference Citation Analysis]